Year: 2022

Cancer Research

Lung Cancer

Lung cancer is a malignant condition that originates in the lungs and is often divided into two main types: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). At Genet, we are committed […]
Cancer Research

Breast Cancer

Breast cancer is a malignant condition that develops in the breast tissue, with invasive ductal carcinoma being the most common form. At Genet, we are committed to advancing clinical research in the field of breast […]
Cancer Research

Gynecological Cancer

Gynecological cancers encompass a group of malignant conditions that affect the female reproductive system, including ovarian, cervical, uterine, and endometrial cancers. At Genet, we are dedicated to advancing clinical research in the field of gynecological […]
Cancer Research

Kidney Cancer

Kidney cancer, also known as renal cancer, is a malignant condition that originates in the kidneys, with the most common type being renal cell carcinoma. At Genet, we are committed to advancing clinical research in […]
Cancer Research

Hematologic

Hematologic malignancies encompass a diverse group of cancers that affect the blood, bone marrow, and lymphatic system, including leukemia, lymphoma, and multiple myeloma. At Genet, we are dedicated to advancing clinical research in the field […]
Cancer Research

Bladder Cancer

Bladder cancer is a malignant condition that arises within the lining of the bladder, with urothelial carcinoma being the most common form. At Genet, we are committed to advancing clinical research in the field of […]
Kidney Cancer

Renal cell carcinoma

Most adults diagnosed with kidney cancer have renal cell carcinoma, which accounts for about 85% of cases. In this type of cancer, the proximal tubules of the kidney’s filtration system are affected.